UNH
33
4
PCAR
48
2
EMR
45
3
HPQ
57
2
EXPD
43
4
DRI
63
2
AVGO
42
-3
OKE
42
3
AIG
54
4
XEL
55
4
WY
36
3
HBAN
53
3
AEP
72
3
MMC
51
4
AN
58
6
MRK
53
7
FAST
55
3
PRGO
24
3
EXC
57
3
MTCH
93
7
UNH
33
4
PCAR
48
2
EMR
45
3
HPQ
57
2
EXPD
43
4
DRI
63
2
AVGO
42
-3
OKE
42
3
AIG
54
4
XEL
55
4
WY
36
3
HBAN
53
3
AEP
72
3
MMC
51
4
AN
58
6
MRK
53
7
FAST
55
3
PRGO
24
3
EXC
57
3
MTCH
93
7
Financhill
Back

Meta Platforms- Ordinary Shares - Class A Vs. Nektar Therapeutics Industry Stock Comparison

Buy
61

META
Meta Platforms- Ordinary Shares - Class A

Last Price:
$782.33
Seasonality Move:
-0.07%
Buy
59

NKTR
Nektar Therapeutics

Last Price:
$26.71
Seasonality Move:
4.65%
Buy
61
Meta Platforms- Ordinary Shares - Class A (META) is a Buy

Is Meta Platforms- Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Meta Platforms- Ordinary Shares - Class A [META] share price is $780.08. The Score for META is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • META is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $25.72. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

META Stock Price Chart

What is Meta Platforms- Ordinary Shares - Class A's stock price today?

  • The Meta Platforms- Ordinary Shares - Class A share price today is $780.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $25.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

META Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 204.56 Buy
Relative Strength Index (14 RSI): 61.98 Buy
Chaikin Money Flow: -6919071 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (703.6 - 765.1) Buy
Bollinger Bands (100): (572.55 - 731.47) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 61.8 Buy
Chaikin Money Flow: 677331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.56 - 25.12) Buy
Bollinger Bands (100): (8.21 - 22.19) Buy

META Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 772.36 Buy
20-day SMA: 738.99 Buy
50-day SMA: 719.62 Buy
200-day SMA: 636.86 Buy
8-day EMA: 733.87 Buy
20-day EMA: 534.62 Buy
50-day EMA: 290.11 Buy
200-day EMA: 85.81 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.11 Buy
20-day SMA: 23.68 Buy
50-day SMA: 20.19 Buy
200-day SMA: 15.03 Buy
8-day EMA: 23.52 Buy
20-day EMA: 23.17 Buy
50-day EMA: 20.66 Buy
200-day EMA: 16.42 Buy

Meta Platforms- Ordinary Shares - Class A Earnings Growth & META Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.27 per share, an increase next quarter of $0.60 per share, an increase this year of $5.14 per share, and an increase next year of $1.84 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

Meta Platforms- Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):